Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric ropivacaine versus hyperbaric bupivacaine for spinal anesthesia in elective caesarean delivery
IRCT20221109056455N1Phase 3Completed
- Sponsor
- Tata Main Hospital
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ropivacaine and bupivacaine in None (2 arms), sponsored by Tata Main Hospital. Primary endpoints: Duration of motor blockade, Onset of sensory block and 2 more. Started Aug 2023; status: completed.
02
Drugs
ropivacainebupivacaine
Beyond the preview
Go deeper on IRCT20221109056455N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221109056455N1.